Survey on patient-group views about pharma’s impact on the environment and society, 2024
No images? Click here
Study into Pharma’s ESG (Environment, Society, Governance) strategies, 2024:
Have your say!
For weblink, see below
WEBLINK to the survey: ‘Study into patient-group views on pharma’s ESG activities, 2024’
https://www.surveymonkey.com/r/Pharma-ESG-and-patient-groups-North-America-2024
(PLEASE WAIT A FEW SECONDS TO REACH THE ONLINE LINK)
For the attention of: health campaigners
We are approaching your organization as a key health campaigner in your field to obtain your views on pharma’s impact on the environment and health in 2024.
Some background
The term ‘ESG’ was introduced in 2005 by the United Nations Global Compact Office to ensure that companies consider, not just profitability, but also the planet’s sustainability. ESG is generally taken to mean …
- Environment (E).
- Social/society (S).
- Governance (G).
The aim of the survey
The survey aims to discover your organization’s views on:
- Whether pharma’s ESG goals and strategies have any impact on YOUR patient group.
- Your patient group’s understanding of whether pharma’s ESG goals and strategies have any impact on the public (that is, ON SOCIETY IN GENERAL). And, finally ...
- How you would like pharma to ENGAGE WITH YOUR patient group on the subject of pharma ESG.
About PatientView
PatientView is an independent research organization that studies issues of concern to patient groups and health campaigners.
Why your opinions are important
This survey offers patient groups a unique chance to amplify the patient voice in discussions about pharma’s ESG activities. The results should help pharma develop, and improve, its ESG—alongside patient populations.
Key points about this survey
- Feedback of results to you. As a patient-group representative responding to this study, you will be entitled to receive a free copy of the results of this survey, upon publication (November 2024), if you wish.
- Your anonymity. The survey’s questionnaire is being carried on a specialist survey website, so allowing all responses to be completely anonymous (unless you wish otherwise).
- What this survey is not about. Charitable donations made by pharmaceutical companies. The survey focus is purely on ESG issues.
The closing date for this PatientView survey is Thursday, October 31st 2024
WEBLINK to the survey: ‘Study into patient-group views on pharma’s ESG activities, 2024’
https://www.surveymonkey.com/r/Pharma-ESG-and-patient-groups-North-America-2024
(PLEASE WAIT A FEW SECONDS TO REACH THE ONLINE LINK)
If you have any questions, please contact me:
Dr. Alexandra Wyke,
CEO,
PatientView,
London, UK
- e-mail: alexwyke @ patient-view.com
- Tel: +44-(0)7960-855-019
